- Home
- / Strides Pharma
Strides Pharma
Revenue
₹30.2 B
FY, 2022
Market Capitalization
₹29.5 B
2023-01-20
Strides Pharma Summary
Company summary
- Overview
- Strides Pharma Science (formerly known as Strides Shasun) is a pharmaceutical company with a focus on the development and manufacture of IP-led niche finished dosage formulations. It is also engaged in the manufacturing of soft gelatin capsules.
- Type
- Public
- Status
- Active
- Founded
- 1990
- HQ
- Bengaluru, IN | view all locations
- Website
- http://www.strides.com/
- Cybersecurity rating
Key people
S. Sridhar, Independent Director
Anjani Kumar, Chief Information Officer
Bharat Shah, Director
LocationsView all
5 locations detected
Bengaluru, KA HQ
India
Krishnaraju Layout, Amalodbhavi Nagar, Panduranga Nagar
East Brunswick, NJ
United States
2 Tower Center Blvd #1102
Lambertville, NJ
United States
201 S Main St #3
Navi Mumbai, MH
India
Devavrata Building, Palm Beach Rd, Sector 17, Vashi
Watford, England
United Kingdom
Unit 4 (side entrance, Metro Centre, Off Dwight Rd, Tolpits Ln
Strides Pharma Financials
Summary financials
- Revenue (FY, 2022)
- ₹30.2B
- Gross profit (FY, 2022)
- ₹14.9B
- Net income (FY, 2022)
- (₹4.7B)
- Cash (FY, 2022)
- ₹1.9B
- EBIT (FY, 2022)
- (₹5.9B)
- Enterprise value
- $57.9B
Footer menu
Products
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension